Velan Capital Investment Management LP Portfolio Holdings

Velan Capital Investment Management LP

  • $48.3 Million
  • Q3 2024

Velan Capital Investment Management LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $48.3 Million distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Heron Therapeutics, Inc. with a value of $13.9M, Rezolute, Inc. with a value of $3.88M, Liquidia Corp with a value of $3M, Context Therapeutics Inc. with a value of $2.53M, and Inspire Md, Inc. with a value of $2.42M.

Examining the 13F form we can see an increase of $6.46M in the current position value, from $41.8M to 48.3M.

Velan Capital Investment Management LP is based out at Alpharetta, GA

Below you can find more details about Velan Capital Investment Management LP portfolio as well as his latest detailed transactions.

Portfolio value $48.3 Million
Healthcare: $33.5 Million
ETFs: $14.8 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$188M
$13.9 Million 28.8% of portfolio
6,986,744
Q3 2023 Added 55.26%
$166M
$3.88 Million 8.03% of portfolio
800,000
Q2 2024 Added 100.0%
$714M
$3 Million 6.21% of portfolio
300,000
Q3 2024 New
$16.3M
$2.53 Million 5.24% of portfolio
1,290,323
Q2 2024 New
$25M
$2.42 Million 5.02% of portfolio
904,029
Q2 2023 New
$92.9M
$2.36 Million 4.89% of portfolio
517,668
Q3 2024 New
$54.6M
$1.89 Million 3.91% of portfolio
747,410
Q3 2024 Added 0.18%
$35M
$1.44 Million 2.98% of portfolio
2,146,608
Q3 2024 Reduced 13.89%
$60.7M
$1.05 Million 2.17% of portfolio
574,000
Q3 2024 Added 19.58%
$170M
$988,000 2.05% of portfolio
200,000
Q3 2024 New
Kiora Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 2.59%
Skye Bioscience Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 50.0%
Corbus Pharmaceuticals Hldgs
-
$0 0.0% of portfolio
-
Q3 2024 New
Tenax Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 3.8%

Summary

  • Portfolio
  • No. of Stocks 20
  • Current Value $48.3 Million
  • Prior Value $41.8 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 5 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email